title: Rapid reporting and review of an increased incidence of a known adverse event.
authors.affiliation: Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA. sargent.daniel@mayo.edu
authors.forename: D J
authors.initials: DJ
authors.lastname: Sargent
authors.forename: R M
authors.initials: RM
authors.lastname: Goldberg
authors.forename: M R
authors.initials: MR
authors.lastname: Mahoney
authors.forename: D W
authors.initials: DW
authors.lastname: Hillman
authors.forename: T
authors.initials: T
authors.lastname: McKeough
authors.forename: S F
authors.initials: SF
authors.lastname: Hamilton
authors.forename: J M
authors.initials: JM
authors.lastname: Darcy
authors.forename: V L
authors.initials: VL
authors.lastname: Anderson
authors.forename: J E
authors.initials: JE
authors.lastname: Krook
authors.forename: M J
authors.initials: MJ
authors.lastname: O'Connell
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000458:organization & administration* / Q000592:standards; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic / Q000592:standards*; D017321:Clinical Trials, Phase I as Topic / Q000592:standards; D017322:Clinical Trials, Phase II as Topic / Q000592:standards; D017326:Clinical Trials, Phase III as Topic / Q000592:standards; D003967:Diarrhea / Q000139:chemically induced; D015507:Drugs, Investigational / Q000009:adverse effects; D006801:Humans; D015994:Incidence; D015337:Multicenter Studies as Topic / Q000592:standards*; D009316:National Institutes of Health (U.S.); D009503:Neutropenia / Q000139:chemically induced; D014481:United States; D014486:United States Food and Drug Administration; D014839:Vomiting / Q000139:chemically induced
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational